The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Nano Antibodies Market Research Report 2025

Global Nano Antibodies Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1711238

No of Pages : 69

Ask Your Query

Synopsis

Market Analysis and Insights: Global Nano Antibodies Market
Nanoantibodies or "nAb" are single-domain VHH antibodies derived from camelidae (camels, llamas, alpacas, etc.). Compared with conventional monoclonal and polyclonal antibodies, nAbs have the following advantages:
Small size (~15kd)
High affinity (frequently nanomolar range)
High specificity
Unsurpassed stability

The global Nano Antibodies market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Monovalent Nanobody accounting for % of the Nano Antibodies global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Disease detection in vitro segment is altered to an % CAGR throughout this forecast period.
China Nano Antibodies market size is valued at US$ million in 2021, while the North America and Europe Nano Antibodies are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Nano Antibodies landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nano Antibodies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nano Antibodies market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nano Antibodies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nano Antibodies market.

Global Nano Antibodies Scope and Market Size
Nano Antibodies market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Nano Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Monovalent Nanobody
  • Multivalent and multispecific Nanobodies
  • Fusion Nanobody

Segment by Application

  • Disease detection in vitro
  • Non-invasive diagnosis in vivo
  • Tumor targeted therapy
  • Nervous system disease
  • Circulatory disease
  • Infectious disease
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia) 
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Ablynx
  • PREGENE
  • Alphamab
  • PersonGen
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nano Antibodies Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Monovalent Nanobody
1.2.3 Multivalent and multispecific Nanobodies
1.2.4 Fusion Nanobody
1.3 Market by Application
1.3.1 Global Nano Antibodies Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Disease detection in vitro
1.3.3 Non-invasive diagnosis in vivo
1.3.4 Tumor targeted therapy
1.3.5 Nervous system disease
1.3.6 Circulatory disease
1.3.7 Infectious disease
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nano Antibodies Market Perspective (2017-2028)
2.2 Nano Antibodies Growth Trends by Region
2.2.1 Nano Antibodies Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nano Antibodies Historic Market Size by Region (2017-2022)
2.2.3 Nano Antibodies Forecasted Market Size by Region (2023-2028)
2.3 Nano Antibodies Market Dynamics
2.3.1 Nano Antibodies Industry Trends
2.3.2 Nano Antibodies Market Drivers
2.3.3 Nano Antibodies Market Challenges
2.3.4 Nano Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nano Antibodies Players by Revenue
3.1.1 Global Top Nano Antibodies Players by Revenue (2017-2022)
3.1.2 Global Nano Antibodies Revenue Market Share by Players (2017-2022)
3.2 Global Nano Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nano Antibodies Revenue
3.4 Global Nano Antibodies Market Concentration Ratio
3.4.1 Global Nano Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nano Antibodies Revenue in 2021
3.5 Nano Antibodies Key Players Head office and Area Served
3.6 Key Players Nano Antibodies Product Solution and Service
3.7 Date of Enter into Nano Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nano Antibodies Breakdown Data by Type
4.1 Global Nano Antibodies Historic Market Size by Type (2017-2022)
4.2 Global Nano Antibodies Forecasted Market Size by Type (2023-2028)
5 Nano Antibodies Breakdown Data by Application
5.1 Global Nano Antibodies Historic Market Size by Application (2017-2022)
5.2 Global Nano Antibodies Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nano Antibodies Market Size (2017-2028)
6.2 North America Nano Antibodies Market Size by Country (2017-2022)
6.3 North America Nano Antibodies Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Nano Antibodies Market Size (2017-2028)
7.2 Europe Nano Antibodies Market Size by Country (2017-2022)
7.3 Europe Nano Antibodies Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nano Antibodies Market Size (2017-2028)
8.2 Asia-Pacific Nano Antibodies Market Size by Country (2017-2022)
8.3 Asia-Pacific Nano Antibodies Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Nano Antibodies Market Size (2017-2028)
9.2 Latin America Nano Antibodies Market Size by Country (2017-2022)
9.3 Latin America Nano Antibodies Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nano Antibodies Market Size (2017-2028)
10.2 Middle East & Africa Nano Antibodies Market Size by Country (2017-2022)
10.3 Middle East & Africa Nano Antibodies Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Ablynx
11.1.1 Ablynx Company Detail
11.1.2 Ablynx Business Overview
11.1.3 Ablynx Nano Antibodies Introduction
11.1.4 Ablynx Revenue in Nano Antibodies Business (2017-2022)
11.1.5 Ablynx Recent Development
11.2 PREGENE
11.2.1 PREGENE Company Detail
11.2.2 PREGENE Business Overview
11.2.3 PREGENE Nano Antibodies Introduction
11.2.4 PREGENE Revenue in Nano Antibodies Business (2017-2022)
11.2.5 PREGENE Recent Development
11.3 Alphamab
11.3.1 Alphamab Company Detail
11.3.2 Alphamab Business Overview
11.3.3 Alphamab Nano Antibodies Introduction
11.3.4 Alphamab Revenue in Nano Antibodies Business (2017-2022)
11.3.5 Alphamab Recent Development
11.4 PersonGen
11.4.1 PersonGen Company Detail
11.4.2 PersonGen Business Overview
11.4.3 PersonGen Nano Antibodies Introduction
11.4.4 PersonGen Revenue in Nano Antibodies Business (2017-2022)
11.4.5 PersonGen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Nano Antibodies Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Monovalent Nanobody
Table 3. Key Players of Multivalent and multispecific Nanobodies
Table 4. Key Players of Fusion Nanobody
Table 5. Global Nano Antibodies Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Nano Antibodies Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Nano Antibodies Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Nano Antibodies Market Share by Region (2017-2022)
Table 9. Global Nano Antibodies Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Nano Antibodies Market Share by Region (2023-2028)
Table 11. Nano Antibodies Market Trends
Table 12. Nano Antibodies Market Drivers
Table 13. Nano Antibodies Market Challenges
Table 14. Nano Antibodies Market Restraints
Table 15. Global Nano Antibodies Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Nano Antibodies Market Share by Players (2017-2022)
Table 17. Global Top Nano Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nano Antibodies as of 2021)
Table 18. Ranking of Global Top Nano Antibodies Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Nano Antibodies Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Nano Antibodies Product Solution and Service
Table 22. Date of Enter into Nano Antibodies Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nano Antibodies Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Nano Antibodies Revenue Market Share by Type (2017-2022)
Table 26. Global Nano Antibodies Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Nano Antibodies Revenue Market Share by Type (2023-2028)
Table 28. Global Nano Antibodies Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Nano Antibodies Revenue Market Share by Application (2017-2022)
Table 30. Global Nano Antibodies Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Nano Antibodies Revenue Market Share by Application (2023-2028)
Table 32. North America Nano Antibodies Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Nano Antibodies Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Nano Antibodies Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Nano Antibodies Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Nano Antibodies Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Nano Antibodies Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Nano Antibodies Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Nano Antibodies Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Nano Antibodies Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Nano Antibodies Market Size by Country (2023-2028) & (US$ Million)
Table 42. Ablynx Company Detail
Table 43. Ablynx Business Overview
Table 44. Ablynx Nano Antibodies Product
Table 45. Ablynx Revenue in Nano Antibodies Business (2017-2022) & (US$ Million)
Table 46. Ablynx Recent Development
Table 47. PREGENE Company Detail
Table 48. PREGENE Business Overview
Table 49. PREGENE Nano Antibodies Product
Table 50. PREGENE Revenue in Nano Antibodies Business (2017-2022) & (US$ Million)
Table 51. PREGENE Recent Development
Table 52. Alphamab Company Detail
Table 53. Alphamab Business Overview
Table 54. Alphamab Nano Antibodies Product
Table 55. Alphamab Revenue in Nano Antibodies Business (2017-2022) & (US$ Million)
Table 56. Alphamab Recent Development
Table 57. PersonGen Company Detail
Table 58. PersonGen Business Overview
Table 59. PersonGen Nano Antibodies Product
Table 60. PersonGen Revenue in Nano Antibodies Business (2017-2022) & (US$ Million)
Table 61. PersonGen Recent Development
Table 62. Research Programs/Design for This Report
Table 63. Key Data Information from Secondary Sources
Table 64. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nano Antibodies Market Share by Type: 2021 VS 2028
Figure 2. Monovalent Nanobody Features
Figure 3. Multivalent and multispecific Nanobodies Features
Figure 4. Fusion Nanobody Features
Figure 5. Global Nano Antibodies Market Share by Application in 2021 & 2028
Figure 6. Disease detection in vitro Case Studies
Figure 7. Non-invasive diagnosis in vivo Case Studies
Figure 8. Tumor targeted therapy Case Studies
Figure 9. Nervous system disease Case Studies
Figure 10. Circulatory disease Case Studies
Figure 11. Infectious disease Case Studies
Figure 12. Other Case Studies
Figure 13. Nano Antibodies Report Years Considered
Figure 14. Global Nano Antibodies Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Nano Antibodies Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Nano Antibodies Market Share by Region: 2021 VS 2028
Figure 17. Global Nano Antibodies Market Share by Players in 2021
Figure 18. Global Top Nano Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nano Antibodies as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Nano Antibodies Revenue in 2021
Figure 20. North America Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Nano Antibodies Market Share by Country (2017-2028)
Figure 22. United States Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Nano Antibodies Market Share by Country (2017-2028)
Figure 26. Germany Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Nano Antibodies Market Share by Region (2017-2028)
Figure 34. China Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Nano Antibodies Market Share by Country (2017-2028)
Figure 42. Mexico Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Nano Antibodies Market Share by Country (2017-2028)
Figure 46. Turkey Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Nano Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Ablynx Revenue Growth Rate in Nano Antibodies Business (2017-2022)
Figure 49. PREGENE Revenue Growth Rate in Nano Antibodies Business (2017-2022)
Figure 50. Alphamab Revenue Growth Rate in Nano Antibodies Business (2017-2022)
Figure 51. PersonGen Revenue Growth Rate in Nano Antibodies Business (2017-2022)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock